Development of folate-conjugated PEGylated poly (d,l-lactide-co-glycolide) nanoparticulate carrier for docetaxel

Current Nanoscience

Volumn 4, Issue 4, 2008, Pages 402-408

  Murugesan, Senthilkumar ^a   Mishra, Pradeep ^a   Jain, Narendra Kumar ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Cytotoxicity; Diblock; Docetaxel; Folate; Nanoparticles; PLGA PEG

Indexed keywords

ANTINEOPLASTIC AGENTS; CELL LINES; DELIVERY MODES; DIBLOCK; DIBLOCK COPOLYMER; DOCETAXEL; DRUG ENTRAPMENT; EMULSION SOLVENT EVAPORATION; FOLATE; FOLATE CONTENT; IN-VITRO; MTT ASSAYS; NANO PARTICULATES; PLGA NANOPARTICLES; PLGA-PEG; POLY(D ,L-LACTIDE-CO- GLYCOLIDE); RELEASE RATE; SODIUM CHOLATE; SURFACE DENSITY; SURFACE-MODIFIED;

BLOCK COPOLYMERS; CELL CULTURE; CHROMATOGRAPHIC ANALYSIS; CONTROLLED DRUG DELIVERY; COPOLYMERIZATION; CYTOTOXICITY; EMULSIFICATION; GELATION; NANOPARTICLES; ORGANIC POLYMERS; POLYETHYLENE OXIDES; SODIUM; SURFACE ACTIVE AGENTS; SURFACE PROPERTIES; SYNTHESIS (CHEMICAL);

POLYETHYLENE GLYCOLS;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CHOLIC ACID; COPOLYMER; DOCETAXEL; DRUG CARRIER; FOLIC ACID; MACROGOL; NANOPARTICLE; POLYGLACTIN; SOLVENT; SURFACTANT;

CELL ASSAY; CELL STRAIN KB; CHEMICAL COMPOSITION; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; COVALENT BOND; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; EMULSION; EVAPORATION; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SURFACE CHARGE; SURFACE PROPERTY;

EID: 65749090804     PISSN: 15734137     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341308786306152     Document Type: Review

References (21)

1. Rowinsky, E.K. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu. Rev. Med., 1997, 48, 353.
2. Capri, G.; Tarenzi, E.; Fulfaro, F.; Gianni, L. The role of taxanes in the treatment of breast cancer. Semin. Oncol., 1996, 23, 68.
3. Khalid, M.N.; Simard, P.; Hoarau, D.; Dragomir, A.; Leroux, J.C. Long circulating poly(ethyleneglycol)-decorated lipid nanocapsules deliver Docetaxel to solid tumors. Pharm. Res., 2006, 23, 752.
4. Immordino, M.L.; Brusa, P.; Arpicco, S.; Stella, B.; Dosio, F.; Cattel, L. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing Docetaxel. J. Control. Release, 2003, 91, 417.
5. Grosse, P.Y.; Bressolle, F.; Pinguet, F. In vitro modulation of doxorubicin and Docetaxel antitumoral activity by methyl-β-cyclodextrin. Eur. J. Cancer, 1998, 34, 168.
6. Chenga, J.; Teply, B.A.; Sherifia, I.; Sunga, J.; Luthera, G.; Gua, F.X.; Nissenbaum, E.L.; Radovic-Moreno, A.F.; Langer, R.; Farokhzad, O.C. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials, 2007, 28, 869.
7. Hans, M.L.; Lowman, A.M. Biodegradable nanoparticles for drug delivery and targeting. Curr. Opin. Solid State Mater. Sci., 2002, 6, 319.
8. Gref, R.; Domb, A.; Quelle, P.; Blunk, T.; Miiller, R.H.; Verbavatz, J.M.; Langer, R. The controlled intravenous delivery of drugs using PEG coated sterically stabilized nanospheres. Adv. Drug Deliv. Rev., 1995, 16, 215.
9. Yokoyama, M.; Okano, T.; Sakurai, Y.; Fukushima, S.; Okamoto, K.; Kataoka, K. Selective delivery of adiramycin to a solid tumor using a polymeric micelle carrier system. J. Drug Target, 1999, 7, 171.
10. Yoo, H.S.; Park, T.G. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J. Control. Release, 2004, 100, 247.
11. Seow, W.Y.; Xue, J.M.; Yang, Y.Y. Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles. Biomaterials, 2007, 28, 1730.
12. Yoon, J.J.; Nam, Y.S.; Kim, J.H.; Park, T.G. Surface immobilization of galactose onto aliphatic biodegradable polymers for hepatocyte culture. Biotechnol. Bioeng., 2002, 78, 1.
13. Yoo, H.S.; Park, T.G. Folate receptor targeted biodegradable polymeric doxorubicin micells. J. Control. Release, 2004, 96, 273.
14. Senthilkumar, M.; Subramanian, G.; Ranjit kumar, A.; Nahar, M.; Misha, P.; Jain, N.K. PEGylated Poly (Lactide-co-Glycolide) (PLGA) nanoparticulate delivery of Docetaxel: synthesis of diblock copolymers, optimization of preparation variables on formulation characteristics and in vitro release studies. J. Biomed. Nanotech., 2007, 3, 52.
15. Stella, B.; Aripicco, S.; Peracchia, M.T.; Desmaele, D.; Hoebeke, J.; Renoir, M.; D'Angelo, J.; Cattel, L.; Couvreur, P. Design of folic acid conjugated nanoparticles for drug targeting. J. Pharm. Sci., 2000, 89, 1452.
16. Shi, B.; Fang, C.; Pei, Y. Stealth PEG-PHDCA niosomes: Effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, In vivo pharmacokinetics and antitumor activity. J. Pharm. Sci., 2006, 95, 1873.
17. Vijayan, P.; Vijayaraj, P.; Setty, P.H.C.; Hariharapura, R.C.; Godavarthi, A.; Badami, S.; Arumugam, D.S.; Bhojraj, S. The cytotoxicity activity of the total alkaloids isolated from different parts of Solanum pseudocapsicum. Biol. Pharm. Bull., 2004, 27, 528.
18. Sahoo, S.K.; Panyam, J.; Prabha, S.; Labhasetwar, V. Residual polyvinyl alcohol associated with poly (lactic-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Control. Release, 2002, 82, 105.
19. Gref, R.; Luck, M.; Quellec, P.; Marchand, M.; Dellacherie, E.; Harnisch, S.; Blunk, T.; Muller, R.H. Stealth corona-core nanoparticles surface modifided by polyethylene glycol (PEG): influence of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf. B. Biointerfaces, 2000, 18, 301.
20. Panyam, J.; Labhasetwar, V. Dyanamics of endocytosis and exocytosis of poly d,1-lactide-co-glycolide nanoparticles in vascular smooth muscle cells. Pharm. Res., 2003, 20, 212.
21. Senthilkumar, M.; Pradeep Mishra.; Jain. N.K. Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors. J. Drug Target, 2008, 16, 424.